Company
Valion Bio, Inc. (VBIO)
Standardized SEC financial data for Valion Bio, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001787740 · NASDAQ · Electromedical & Electrotherapeutic Apparatus.
Revenue growth (YoY)
-33.7%
Return on equity
-52.9%
Free cash flow
-$6.7M
Current ratio
20.13×
EPS (diluted)
$-19.68
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.3M | $1.8M | $1.2M | $780K | — |
| Cost of revenue | $1.3M | $1.5M |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.5M | $3.4M | $2.0M | — | — | $12.6M |
| Inventory |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$5.6M | -$8.9M | -$8.5M | -$5.7M | -$7.0M |
| Capital expenditures | — | $11K |
Get VBIO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/VBIO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/VBIO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"